Dataset | Score | p-value 1 | p-value 2 | p-value 3 |
---|---|---|---|---|
chia-screen-data-Fav | 2.860 | 9.00e-16 | 3.59e-04 | 2.74e-03 |
Gene Symbol | Entrez Gene ID | Frequency | chia-screen-data-Fav gene score | Best subnetwork score | Degree | Chia-Hits Primary | Chia-Hits Secondary |
---|---|---|---|---|---|---|---|
RNF40 | 9810 | 2 | -2.082 | 2.938 | 25 | Yes | - |
HCFC1 | 3054 | 40 | -2.925 | 3.449 | 71 | Yes | Yes |
APLP2 | 334 | 12 | -2.732 | 3.206 | 35 | Yes | Yes |
MED19 | 219541 | 30 | -2.657 | 3.449 | 115 | Yes | - |
MCRS1 | 10445 | 14 | -2.660 | 3.079 | 63 | Yes | Yes |
TNFAIP8 | 25816 | 1 | -1.978 | 2.860 | 7 | - | - |
LUC7L3 | 51747 | 33 | -3.523 | 3.449 | 18 | Yes | - |
MED28 | 80306 | 16 | -2.404 | 3.216 | 80 | Yes | - |
YAP1 | 10413 | 94 | -4.256 | 3.538 | 53 | Yes | - |
MED12 | 9968 | 14 | -2.465 | 3.206 | 65 | Yes | - |
MED17 | 9440 | 2 | -2.161 | 2.860 | 51 | Yes | - |
NFRKB | 4798 | 48 | -3.129 | 3.108 | 23 | Yes | Yes |
SRSF3 | 6428 | 73 | -2.992 | 3.538 | 54 | Yes | - |
POU5F1 | 5460 | 133 | -5.148 | 3.538 | 179 | Yes | Yes |
[ MED4 ] | 29079 | 2 | -1.785 | 2.860 | 44 | - | - |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
SRSF3 | 6428 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: IntAct |
MED17 | 9440 | MED4 | 29079 | pp | -- | int.I2D: IntAct_Fly |
HCFC1 | 3054 | POU5F1 | 5460 | pp | -- | int.I2D: BioGrid_Mouse, IntAct_Mouse |
MED17 | 9440 | MED12 | 9968 | pp | -- | int.I2D: BioGrid |
MCRS1 | 10445 | MED4 | 29079 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid, HPRD, MINT, VidalHuman_core, IntAct; int.Mint: MI:0915(physical association); int.HPRD: yeast 2-hybrid |
HCFC1 | 3054 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: IntAct |
NFRKB | 4798 | POU5F1 | 5460 | pp | -- | int.I2D: BioGrid_Mouse, IntAct_Mouse |
MED28 | 80306 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid, IntAct |
YAP1 | 10413 | MED28 | 80306 | pp | -- | int.I2D: MINT; int.Mint: MI:0915(physical association) |
MED4 | 29079 | MED28 | 80306 | pp | -- | int.I2D: BioGrid |
APLP2 | 334 | MED12 | 9968 | pp | -- | int.I2D: MINT; int.Mint: MI:0407(direct interaction) |
NFRKB | 4798 | MCRS1 | 10445 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid |
MED17 | 9440 | MED28 | 80306 | pp | -- | int.I2D: BioGrid, BioGrid_Fly, IntAct_Fly |
MED12 | 9968 | MED28 | 80306 | pp | -- | int.I2D: BioGrid |
MED12 | 9968 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid, IntAct |
TNFAIP8 | 25816 | MED4 | 29079 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid, MINT, VidalHuman_core, HPRD, IntAct; int.Mint: MI:0915(physical association); int.HPRD: yeast 2-hybrid |
MED17 | 9440 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid, IntAct, BIND, HPRD; int.HPRD: in vitro |
POU5F1 | 5460 | SRSF3 | 6428 | pp | -- | int.I2D: BioGrid |
LUC7L3 | 51747 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: IntAct |
RNF40 | 9810 | MED4 | 29079 | pp | -- | int.I2D: VidalHuman_non_core |
MED4 | 29079 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid, IntAct |
MED12 | 9968 | MED4 | 29079 | pp | -- | int.I2D: BioGrid, MINT; int.Mint: MI:0915(physical association), MI:0914(association) |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0016592 | mediator complex | 1.84e-10 | 2.66e-06 | 7.102 | 5 | 10 | 35 |
GO:0001104 | RNA polymerase II transcription cofactor activity | 3.04e-08 | 4.39e-04 | 6.865 | 4 | 8 | 33 |
GO:0030518 | intracellular steroid hormone receptor signaling pathway | 3.29e-07 | 4.75e-03 | 7.687 | 3 | 6 | 14 |
GO:0042809 | vitamin D receptor binding | 4.11e-07 | 5.93e-03 | 7.587 | 3 | 6 | 15 |
GO:0006366 | transcription from RNA polymerase II promoter | 2.32e-06 | 3.35e-02 | 3.783 | 6 | 30 | 419 |
GO:0046966 | thyroid hormone receptor binding | 2.33e-06 | 3.36e-02 | 6.794 | 3 | 6 | 26 |
GO:0005654 | nucleoplasm | 3.91e-06 | 5.63e-02 | 2.830 | 8 | 64 | 1082 |
GO:0030521 | androgen receptor signaling pathway | 9.47e-06 | 1.37e-01 | 6.137 | 3 | 5 | 41 |
GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity | 1.10e-05 | 1.58e-01 | 6.068 | 3 | 7 | 43 |
GO:0003712 | transcription cofactor activity | 1.17e-05 | 1.69e-01 | 6.035 | 3 | 8 | 44 |
GO:0019827 | stem cell maintenance | 1.44e-05 | 2.07e-01 | 5.940 | 3 | 7 | 47 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 3.14e-05 | 4.52e-01 | 4.386 | 4 | 22 | 184 |
GO:0043995 | histone acetyltransferase activity (H4-K5 specific) | 3.62e-05 | 5.22e-01 | 7.739 | 2 | 5 | 9 |
GO:0046972 | histone acetyltransferase activity (H4-K16 specific) | 3.62e-05 | 5.22e-01 | 7.739 | 2 | 5 | 9 |
GO:0043996 | histone acetyltransferase activity (H4-K8 specific) | 3.62e-05 | 5.22e-01 | 7.739 | 2 | 5 | 9 |
GO:0003713 | transcription coactivator activity | 8.41e-05 | 1.00e+00 | 4.020 | 4 | 24 | 237 |
GO:0031011 | Ino80 complex | 9.12e-05 | 1.00e+00 | 7.102 | 2 | 6 | 14 |
GO:0043981 | histone H4-K5 acetylation | 1.05e-04 | 1.00e+00 | 7.002 | 2 | 5 | 15 |
GO:0043982 | histone H4-K8 acetylation | 1.05e-04 | 1.00e+00 | 7.002 | 2 | 5 | 15 |
GO:0005634 | nucleus | 1.60e-04 | 1.00e+00 | 1.340 | 12 | 159 | 4559 |
GO:0043984 | histone H4-K16 acetylation | 1.71e-04 | 1.00e+00 | 6.661 | 2 | 5 | 19 |
GO:0000123 | histone acetyltransferase complex | 2.10e-04 | 1.00e+00 | 6.517 | 2 | 6 | 21 |
GO:0006355 | regulation of transcription, DNA-templated | 3.13e-04 | 1.00e+00 | 2.533 | 6 | 43 | 997 |
GO:0071339 | MLL1 complex | 3.49e-04 | 1.00e+00 | 6.154 | 2 | 6 | 27 |
GO:0010467 | gene expression | 4.31e-04 | 1.00e+00 | 2.845 | 5 | 45 | 669 |
GO:0016020 | membrane | 7.94e-04 | 1.00e+00 | 2.001 | 7 | 46 | 1681 |
GO:0004872 | receptor activity | 8.97e-04 | 1.00e+00 | 3.932 | 3 | 8 | 189 |
GO:0060795 | cell fate commitment involved in formation of primary germ layer | 1.04e-03 | 1.00e+00 | 9.909 | 1 | 1 | 1 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 1.04e-03 | 1.00e+00 | 9.909 | 1 | 1 | 1 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway | 1.04e-03 | 1.00e+00 | 9.909 | 1 | 1 | 1 |
GO:0060965 | negative regulation of gene silencing by miRNA | 1.04e-03 | 1.00e+00 | 9.909 | 1 | 1 | 1 |
GO:0006310 | DNA recombination | 2.02e-03 | 1.00e+00 | 4.887 | 2 | 7 | 65 |
GO:0060242 | contact inhibition | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 1 | 2 |
GO:0019046 | release from viral latency | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 2 | 2 |
GO:0009786 | regulation of asymmetric cell division | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 1 | 2 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 2.34e-03 | 1.00e+00 | 3.450 | 3 | 23 | 264 |
GO:0005515 | protein binding | 2.98e-03 | 1.00e+00 | 0.938 | 12 | 198 | 6024 |
GO:0046914 | transition metal ion binding | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 1 | 3 |
GO:0060913 | cardiac cell fate determination | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 1 | 3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 1 | 3 |
GO:0090245 | axis elongation involved in somitogenesis | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 1 | 3 |
GO:0014044 | Schwann cell development | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 4 |
GO:0051151 | negative regulation of smooth muscle cell differentiation | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 4 |
GO:0032611 | interleukin-1 beta production | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 4 |
GO:0033503 | HULC complex | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 4 |
GO:0070461 | SAGA-type complex | 5.19e-03 | 1.00e+00 | 7.587 | 1 | 2 | 5 |
GO:0001714 | endodermal cell fate specification | 5.19e-03 | 1.00e+00 | 7.587 | 1 | 1 | 5 |
GO:0007176 | regulation of epidermal growth factor-activated receptor activity | 5.19e-03 | 1.00e+00 | 7.587 | 1 | 1 | 5 |
GO:0006325 | chromatin organization | 6.50e-03 | 1.00e+00 | 4.027 | 2 | 12 | 118 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 7.47e-03 | 1.00e+00 | 2.285 | 4 | 41 | 789 |
GO:0007617 | mating behavior | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 1 | 8 |
GO:0070688 | MLL5-L complex | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 1 | 8 |
GO:0043254 | regulation of protein complex assembly | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 1 | 8 |
GO:0033523 | histone H2B ubiquitination | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 1 | 8 |
GO:0048188 | Set1C/COMPASS complex | 9.32e-03 | 1.00e+00 | 6.739 | 1 | 4 | 9 |
GO:0035413 | positive regulation of catenin import into nucleus | 1.04e-02 | 1.00e+00 | 6.587 | 1 | 2 | 10 |
GO:0060071 | Wnt signaling pathway, planar cell polarity pathway | 1.04e-02 | 1.00e+00 | 6.587 | 1 | 1 | 10 |
GO:0010390 | histone monoubiquitination | 1.14e-02 | 1.00e+00 | 6.450 | 1 | 1 | 11 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 1.14e-02 | 1.00e+00 | 6.450 | 1 | 4 | 11 |
GO:0045893 | positive regulation of transcription, DNA-templated | 1.22e-02 | 1.00e+00 | 2.593 | 3 | 24 | 478 |
GO:0006878 | cellular copper ion homeostasis | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 1 | 12 |
GO:0035198 | miRNA binding | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 1 | 12 |
GO:0044212 | transcription regulatory region DNA binding | 1.28e-02 | 1.00e+00 | 3.517 | 2 | 17 | 168 |
GO:0016607 | nuclear speck | 1.34e-02 | 1.00e+00 | 3.483 | 2 | 12 | 172 |
GO:0071480 | cellular response to gamma radiation | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 1 | 13 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 2 | 13 |
GO:0005667 | transcription factor complex | 1.39e-02 | 1.00e+00 | 3.458 | 2 | 17 | 175 |
GO:0031625 | ubiquitin protein ligase binding | 1.43e-02 | 1.00e+00 | 3.433 | 2 | 5 | 178 |
GO:0001967 | suckling behavior | 1.45e-02 | 1.00e+00 | 6.102 | 1 | 1 | 14 |
GO:0005685 | U1 snRNP | 1.45e-02 | 1.00e+00 | 6.102 | 1 | 1 | 14 |
GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex | 1.55e-02 | 1.00e+00 | 6.002 | 1 | 3 | 15 |
GO:0001824 | blastocyst development | 1.55e-02 | 1.00e+00 | 6.002 | 1 | 2 | 15 |
GO:0006376 | mRNA splice site selection | 1.55e-02 | 1.00e+00 | 6.002 | 1 | 1 | 15 |
GO:0043274 | phospholipase binding | 1.65e-02 | 1.00e+00 | 5.909 | 1 | 1 | 16 |
GO:0001190 | RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription | 1.65e-02 | 1.00e+00 | 5.909 | 1 | 2 | 16 |
GO:0017075 | syntaxin-1 binding | 1.96e-02 | 1.00e+00 | 5.661 | 1 | 1 | 19 |
GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process | 2.06e-02 | 1.00e+00 | 5.587 | 1 | 1 | 20 |
GO:0014003 | oligodendrocyte development | 2.06e-02 | 1.00e+00 | 5.587 | 1 | 5 | 20 |
GO:0043393 | regulation of protein binding | 2.06e-02 | 1.00e+00 | 5.587 | 1 | 1 | 20 |
GO:0005730 | nucleolus | 2.14e-02 | 1.00e+00 | 1.551 | 5 | 66 | 1641 |
GO:0045787 | positive regulation of cell cycle | 2.26e-02 | 1.00e+00 | 5.450 | 1 | 2 | 22 |
GO:0001205 | RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 2.26e-02 | 1.00e+00 | 5.450 | 1 | 4 | 22 |
GO:0008380 | RNA splicing | 2.28e-02 | 1.00e+00 | 3.076 | 2 | 22 | 228 |
GO:0030864 | cortical actin cytoskeleton | 2.37e-02 | 1.00e+00 | 5.386 | 1 | 1 | 23 |
GO:0035329 | hippo signaling | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 5 | 26 |
GO:0006281 | DNA repair | 2.93e-02 | 1.00e+00 | 2.881 | 2 | 14 | 261 |
GO:0030901 | midbrain development | 2.98e-02 | 1.00e+00 | 5.051 | 1 | 1 | 29 |
GO:0003677 | DNA binding | 3.25e-02 | 1.00e+00 | 1.659 | 4 | 49 | 1218 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 3.28e-02 | 1.00e+00 | 4.909 | 1 | 2 | 32 |
GO:0030178 | negative regulation of Wnt signaling pathway | 3.58e-02 | 1.00e+00 | 4.780 | 1 | 4 | 35 |
GO:0035019 | somatic stem cell maintenance | 4.08e-02 | 1.00e+00 | 4.587 | 1 | 6 | 40 |
GO:0050885 | neuromuscular process controlling balance | 4.08e-02 | 1.00e+00 | 4.587 | 1 | 2 | 40 |
GO:0031124 | mRNA 3'-end processing | 4.28e-02 | 1.00e+00 | 4.517 | 1 | 2 | 42 |
GO:0003682 | chromatin binding | 4.43e-02 | 1.00e+00 | 2.556 | 2 | 19 | 327 |
GO:0050830 | defense response to Gram-positive bacterium | 4.58e-02 | 1.00e+00 | 4.417 | 1 | 3 | 45 |
GO:0006369 | termination of RNA polymerase II transcription | 4.58e-02 | 1.00e+00 | 4.417 | 1 | 2 | 45 |
GO:0030900 | forebrain development | 4.98e-02 | 1.00e+00 | 4.294 | 1 | 1 | 49 |
GO:0009611 | response to wounding | 5.28e-02 | 1.00e+00 | 4.209 | 1 | 5 | 52 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 5.38e-02 | 1.00e+00 | 4.181 | 1 | 5 | 53 |
GO:0008203 | cholesterol metabolic process | 5.77e-02 | 1.00e+00 | 4.076 | 1 | 2 | 57 |
GO:0008013 | beta-catenin binding | 6.06e-02 | 1.00e+00 | 4.002 | 1 | 9 | 60 |
GO:0006406 | mRNA export from nucleus | 6.16e-02 | 1.00e+00 | 3.978 | 1 | 4 | 61 |
GO:0004867 | serine-type endopeptidase inhibitor activity | 6.36e-02 | 1.00e+00 | 3.932 | 1 | 3 | 63 |
GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process | 6.36e-02 | 1.00e+00 | 3.932 | 1 | 4 | 63 |
GO:0000151 | ubiquitin ligase complex | 6.36e-02 | 1.00e+00 | 3.932 | 1 | 1 | 63 |
GO:0010468 | regulation of gene expression | 6.85e-02 | 1.00e+00 | 3.822 | 1 | 2 | 68 |
GO:0007626 | locomotory behavior | 7.14e-02 | 1.00e+00 | 3.759 | 1 | 2 | 71 |
GO:0003729 | mRNA binding | 7.24e-02 | 1.00e+00 | 3.739 | 1 | 4 | 72 |
GO:0001843 | neural tube closure | 7.43e-02 | 1.00e+00 | 3.700 | 1 | 2 | 74 |
GO:0000981 | sequence-specific DNA binding RNA polymerase II transcription factor activity | 7.43e-02 | 1.00e+00 | 3.700 | 1 | 4 | 74 |
GO:0002020 | protease binding | 7.43e-02 | 1.00e+00 | 3.700 | 1 | 6 | 74 |
GO:0060070 | canonical Wnt signaling pathway | 7.53e-02 | 1.00e+00 | 3.680 | 1 | 4 | 75 |
GO:0009653 | anatomical structure morphogenesis | 8.30e-02 | 1.00e+00 | 3.534 | 1 | 2 | 83 |
GO:0006464 | cellular protein modification process | 8.39e-02 | 1.00e+00 | 3.517 | 1 | 4 | 84 |
GO:0050821 | protein stabilization | 8.78e-02 | 1.00e+00 | 3.450 | 1 | 3 | 88 |
GO:0042802 | identical protein binding | 8.85e-02 | 1.00e+00 | 1.990 | 2 | 19 | 484 |
GO:0044822 | poly(A) RNA binding | 9.20e-02 | 1.00e+00 | 1.450 | 3 | 50 | 1056 |
GO:0010951 | negative regulation of endopeptidase activity | 1.03e-01 | 1.00e+00 | 3.209 | 1 | 6 | 104 |
GO:0008201 | heparin binding | 1.20e-01 | 1.00e+00 | 2.978 | 1 | 1 | 122 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 1.23e-01 | 1.00e+00 | 2.932 | 1 | 5 | 126 |
GO:0007507 | heart development | 1.35e-01 | 1.00e+00 | 2.790 | 1 | 7 | 139 |
GO:0010628 | positive regulation of gene expression | 1.42e-01 | 1.00e+00 | 2.719 | 1 | 7 | 146 |
GO:0006974 | cellular response to DNA damage stimulus | 1.46e-01 | 1.00e+00 | 2.671 | 1 | 7 | 151 |
GO:0043005 | neuron projection | 1.51e-01 | 1.00e+00 | 2.615 | 1 | 3 | 157 |
GO:0008022 | protein C-terminus binding | 1.55e-01 | 1.00e+00 | 2.578 | 1 | 8 | 161 |
GO:0000398 | mRNA splicing, via spliceosome | 1.58e-01 | 1.00e+00 | 2.552 | 1 | 15 | 164 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 1.63e-01 | 1.00e+00 | 1.460 | 2 | 39 | 699 |
GO:0007049 | cell cycle | 1.67e-01 | 1.00e+00 | 2.466 | 1 | 6 | 174 |
GO:0003714 | transcription corepressor activity | 1.70e-01 | 1.00e+00 | 2.433 | 1 | 11 | 178 |
GO:0019904 | protein domain specific binding | 1.71e-01 | 1.00e+00 | 2.425 | 1 | 8 | 179 |
GO:0005737 | cytoplasm | 1.74e-01 | 1.00e+00 | 0.615 | 6 | 124 | 3767 |
GO:0032403 | protein complex binding | 1.74e-01 | 1.00e+00 | 2.393 | 1 | 6 | 183 |
GO:0016874 | ligase activity | 2.01e-01 | 1.00e+00 | 2.168 | 1 | 4 | 214 |
GO:0008134 | transcription factor binding | 2.24e-01 | 1.00e+00 | 1.990 | 1 | 18 | 242 |
GO:0043025 | neuronal cell body | 2.27e-01 | 1.00e+00 | 1.973 | 1 | 9 | 245 |
GO:0004842 | ubiquitin-protein transferase activity | 2.35e-01 | 1.00e+00 | 1.915 | 1 | 5 | 255 |
GO:0000166 | nucleotide binding | 2.38e-01 | 1.00e+00 | 1.892 | 1 | 13 | 259 |
GO:0003779 | actin binding | 2.44e-01 | 1.00e+00 | 1.854 | 1 | 10 | 266 |
GO:0006954 | inflammatory response | 2.53e-01 | 1.00e+00 | 1.795 | 1 | 6 | 277 |
GO:0030198 | extracellular matrix organization | 2.57e-01 | 1.00e+00 | 1.765 | 1 | 6 | 283 |
GO:0007186 | G-protein coupled receptor signaling pathway | 2.62e-01 | 1.00e+00 | 1.734 | 1 | 1 | 289 |
GO:0008283 | cell proliferation | 2.92e-01 | 1.00e+00 | 1.552 | 1 | 14 | 328 |
GO:0003723 | RNA binding | 3.02e-01 | 1.00e+00 | 1.491 | 1 | 18 | 342 |
GO:0043565 | sequence-specific DNA binding | 3.05e-01 | 1.00e+00 | 1.475 | 1 | 11 | 346 |
GO:0005925 | focal adhesion | 3.20e-01 | 1.00e+00 | 1.393 | 1 | 9 | 366 |
GO:0043066 | negative regulation of apoptotic process | 3.61e-01 | 1.00e+00 | 1.181 | 1 | 16 | 424 |
GO:0006351 | transcription, DNA-templated | 4.52e-01 | 1.00e+00 | 0.411 | 2 | 57 | 1446 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 4.54e-01 | 1.00e+00 | 0.754 | 1 | 37 | 570 |
GO:0042803 | protein homodimerization activity | 4.69e-01 | 1.00e+00 | 0.692 | 1 | 19 | 595 |
GO:0005739 | mitochondrion | 6.59e-01 | 1.00e+00 | -0.054 | 1 | 23 | 998 |
GO:0008270 | zinc ion binding | 6.59e-01 | 1.00e+00 | -0.052 | 1 | 27 | 997 |
GO:0005829 | cytosol | 7.61e-01 | 1.00e+00 | -0.376 | 2 | 86 | 2496 |
GO:0005886 | plasma membrane | 7.79e-01 | 1.00e+00 | -0.425 | 2 | 49 | 2582 |
GO:0016021 | integral component of membrane | 8.91e-01 | 1.00e+00 | -1.044 | 1 | 17 | 1982 |
GO:0070062 | extracellular vesicular exosome | 9.35e-01 | 1.00e+00 | -1.320 | 1 | 57 | 2400 |